Department of Human Genetics, University of Chicago, Chicago, IL, 60637, USA.
Section of Pulmonary and Critical Care, Department of Medicine, University of Chicago, Chicago, IL, 60637, USA.
Genome Med. 2022 May 24;14(1):55. doi: 10.1186/s13073-022-01058-2.
Genome-wide association studies of asthma have revealed robust associations with variation across the human leukocyte antigen (HLA) complex with independent associations in the HLA class I and class II regions for both childhood-onset asthma (COA) and adult-onset asthma (AOA). However, the specific variants and genes contributing to risk are unknown.
We used Bayesian approaches to perform genetic fine-mapping for COA and AOA (n=9432 and 21,556, respectively; n=318,167 shared controls) in White British individuals from the UK Biobank and to perform expression quantitative trait locus (eQTL) fine-mapping in immune (lymphoblastoid cell lines, n=398; peripheral blood mononuclear cells, n=132) and airway (nasal epithelial cells, n=188) cells from ethnically diverse individuals. We also examined putatively causal protein coding variation from protein crystal structures and conducted replication studies in independent multi-ethnic cohorts from the UK Biobank (COA n=1686; AOA n=3666; controls n=56,063).
Genetic fine-mapping revealed both shared and distinct causal variation between COA and AOA in the class I region but only distinct causal variation in the class II region. Both gene expression levels and amino acid variation contributed to risk. Our results from eQTL fine-mapping and amino acid visualization suggested that the HLA-DQA1*03:01 allele and variation associated with expression of the nonclassical HLA-DQA2 and HLA-DQB2 genes accounted entirely for the most significant association with AOA in GWAS. Our studies also suggested a potentially prominent role for HLA-C protein coding variation in the class I region in COA. We replicated putatively causal variant associations in a multi-ethnic cohort.
We highlight roles for both gene expression and protein coding variation in asthma risk and identified putatively causal variation and genes in the HLA region. A convergence of genomic, transcriptional, and protein coding evidence implicates the HLA-DQA2 and HLA-DQB2 genes and HLA-DQA1*03:01 allele in AOA.
哮喘的全基因组关联研究揭示了人类白细胞抗原(HLA)复合物中的广泛关联,并且在儿童期发病的哮喘(COA)和成年期发病的哮喘(AOA)中,HLA Ⅰ类和Ⅱ类区域均存在独立的关联。然而,导致风险的特定变体和基因尚不清楚。
我们使用贝叶斯方法对来自英国生物库的白种英国人进行了 COA 和 AOA 的遗传精细定位(分别为 9432 例和 21556 例;318167 例共享对照),并在来自不同种族的免疫(淋巴母细胞系,n=398;外周血单核细胞,n=132)和气道(鼻上皮细胞,n=188)细胞中进行了表达数量性状基因座(eQTL)精细定位。我们还从蛋白质晶体结构中检查了假定的因果蛋白编码变异,并在英国生物库的独立多民族队列中进行了复制研究(COA n=1686;AOA n=3666;对照 n=56063)。
遗传精细定位显示,COA 和 AOA 之间在 I 类区域存在共享和独特的因果变异,但仅在 II 类区域存在独特的因果变异。基因表达水平和氨基酸变异均与风险有关。我们来自 eQTL 精细定位和氨基酸可视化的结果表明,HLA-DQA1*03:01 等位基因和与非经典 HLA-DQA2 和 HLA-DQB2 基因表达相关的变异完全解释了 GWAS 中与 AOA 最显著相关的关联。我们的研究还表明,HLA-C 蛋白编码变异在 I 类区域在 COA 中可能具有重要作用。我们在一个多民族队列中复制了假定的因果变异关联。
我们强调了基因表达和蛋白质编码变异在哮喘风险中的作用,并确定了 HLA 区域中的假定因果变异和基因。基因组、转录和蛋白质编码证据的融合表明,HLA-DQA2 和 HLA-DQB2 基因以及 HLA-DQA1*03:01 等位基因与 AOA 相关。